Sofosbuvir is a small molecule antiviral prodrug, metabolized to an active uridine analog that potently inhibits the HCV NS5B RNA-dependent RNA polymerase. It is a key research tool for studying HCV replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of hepatitis C infection.